- Home
- BORR vs PSNL Comparison
BORR vs PSNL Comparison
Compare BORR & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BORR
- PSNL
- Stock Information
- Founded
- BORR 2016
- PSNL 2011
- Country
- BORR Bermuda
- PSNL United States
- Employees
- BORR N/A
- PSNL N/A
- Industry
- BORR Oil & Gas Production
- PSNL Medical Specialities
- Sector
- BORR Energy
- PSNL Health Care
- Exchange
- BORR Nasdaq
- PSNL Nasdaq
- Market Cap
- BORR 909.1M
- PSNL 854.8M
- IPO Year
- BORR 2019
- PSNL 2019
- Fundamental
- Price
- BORR $3.18
- PSNL $7.79
- Analyst Decision
- BORR Hold
- PSNL Strong Buy
- Analyst Count
- BORR 2
- PSNL 7
- Target Price
- BORR $3.75
- PSNL $10.43
- AVG Volume (30 Days)
- BORR 5.7M
- PSNL 1.5M
- Earning Date
- BORR 11-05-2025
- PSNL 11-04-2025
- Dividend Yield
- BORR 1.27%
- PSNL N/A
- EPS Growth
- BORR N/A
- PSNL N/A
- EPS
- BORR 0.28
- PSNL N/A
- Revenue
- BORR $1,024,500,000.00
- PSNL $69,103,000.00
- Revenue This Year
- BORR $0.04
- PSNL N/A
- Revenue Next Year
- BORR N/A
- PSNL $29.83
- P/E Ratio
- BORR $11.29
- PSNL N/A
- Revenue Growth
- BORR 5.83
- PSNL N/A
- 52 Week Low
- BORR $1.55
- PSNL $2.83
- 52 Week High
- BORR $4.23
- PSNL $10.95
- Technical
- Relative Strength Index (RSI)
- BORR 53.88
- PSNL 46.21
- Support Level
- BORR $3.11
- PSNL $6.63
- Resistance Level
- BORR $3.61
- PSNL $9.89
- Average True Range (ATR)
- BORR 0.21
- PSNL 0.80
- MACD
- BORR -0.01
- PSNL -0.21
- Stochastic Oscillator
- BORR 31.01
- PSNL 32.79
About BORR Borr Drilling Limited
Borr Drilling Ltd is a drilling contractor that owns and operates jack-up rigs of modern and high-specification designs providing drilling services to the oil and gas exploration and production industry. The company operates a fleet of around 16 jack-up drilling rigs. Geographically the activities are carried out through Norway.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.